Suppressing the CD200/CD200R signaling pathway through genetic approaches impairs LTP,107 whereas activating CD200/CD200R signaling through pharmacological methods significantly enhances synaptic plasticity by decreasing neuroinflammation in AD and aged mice.105, 106, 108. Here, CD200 is linked to Alzheimer disease.